Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer

Saturday, May 30, 2020

Daiichi Sankyo Company Limited announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck Co Inc Kenilworth New Jersey USA known as MSD outside the United States and Canada to evaluate the combination of...

Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases

Saturday, May 30, 2020

Ligand Pharmaceuticals Incorporated and Icagen a Ligand Company announced today the expansion of Icagens license agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders by ad...

RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy With Merck’s KEYTRUDA® for Certain Late-Stage Cancers

Friday, May 29, 2020

RefleXion Medical a therapeutic oncology company pioneering biologyguided radiotherapy BgRT for treating all stages of cancer today announced a clinical collaboration with Merck known as MSD outside the US and Canada to evaluate the safety and effica...

CordenPharma and Moderna collaborate in obtaining the coronavirus vaccine

Friday, May 29, 2020

CordenPharma a fullservice contract manufacturing and development CDMO organization for the supply of APIs Drug Products and Pharmaceutical Packaging announces the signing of a modification to its agreement to with existing manufacturing Modern Inc...

EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer

Thursday, May 28, 2020

EdiGene Inc which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases and Immunochinaa company dedicated to innovative gene and cellular technology announced that they have fo...

Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

Thursday, May 28, 2020

Gilead Sciences Inc and Arcus Biosciences Inc an oncologyfocused biopharmaceutical company working to create bestinclass cancer therapeutics announced today that the companies have entered into a year partnership to codevelop and cocommercialize curr...

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Wednesday, May 27, 2020

Repare Therapeutics Inc Repare a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations today announced it has entered into an...

ArcherDX Announces Strategic Collaboration with AstraZeneca

Wednesday, May 27, 2020

ArcherDX Inc announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase clinical trials for AstraZenecas targeted immunooncology therapeutics

Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)

Tuesday, May 26, 2020

ONCODESIGN announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities spanning from Hit finding up to preparation of the Investigational New Drug filing

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies

Tuesday, May 26, 2020

Tavotek Biotherapeutics a biotech company which develops novel biologics for autoimmune diseases and oncology announced that it has entered into a research agreement with Genmab AS of Denmark to create and develop bispecific antibodies using Genmabs...